21-33271777-G-T
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000628.5(IL10RB):c.173+3260G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.229 in 151,740 control chromosomes in the GnomAD database, including 4,417 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_000628.5 intron
Scores
Clinical Significance
Conservation
Publications
- inflammatory bowel disease 25Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- IL10-related early-onset inflammatory bowel diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000628.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| IL10RB | TSL:1 MANE Select | c.173+3260G>T | intron | N/A | ENSP00000290200.2 | Q08334 | |||
| IFNAR2-IL10RB | TSL:5 | c.833+3260G>T | intron | N/A | ENSP00000388223.3 | H0Y3Z8 | |||
| IL10RB | c.173+3260G>T | intron | N/A | ENSP00000566272.1 |
Frequencies
GnomAD3 genomes AF: 0.229 AC: 34768AN: 151624Hom.: 4415 Cov.: 31 show subpopulations
GnomAD4 genome AF: 0.229 AC: 34782AN: 151740Hom.: 4417 Cov.: 31 AF XY: 0.236 AC XY: 17472AN XY: 74134 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.